Literature DB >> 10403380

Polyunsaturated fatty acids potentiate interleukin-1-stimulated arachidonic acid release by cells overexpressing type IIA secretory phospholipase A2.

T Kambe1, M Murakami, I Kudo.   

Abstract

By analyzing human embryonic kidney 293 cell transfectants stably overexpressing various types of phospholipase A2 (PLA2), we have shown that polyunsaturated fatty acids (PUFAs) preferentially activate type IIA secretory PLA2 (sPLA2-IIA)-mediated arachidonic acid (AA) release from interleukin-1 (IL-1)-stimulated cells. When 293 cells prelabeled with 13H]AA were incubated with exogenous PUFAs in the presence of IL-1 and serum, there was a significant increase in [3H]AA release (in the order AA > linoleic acid > oleic acid), which was augmented markedly by sPLA2-IIA and modestly by type IV cytosolic PLA2 (cPLA2), but only minimally by type VI Ca2(+)-independent PLA2, overexpression. Transfection of cPLA2 into sPLA2-IIA-expressing cells produced a synergistic increase in IL-1-dependent [3H]AA release and subsequent prostaglandin production. Our results support the proposal that prior production of AA by cPLA2 in cytokine-stimulated cells destabilizes the cellular membranes, thereby rendering them more susceptible to subsequent hydrolysis by sPLA2-IIA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10403380     DOI: 10.1016/s0014-5793(99)00702-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis.

Authors:  M S Caplan; T Jilling
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

Review 2.  Fatty Acid Metabolism and T Cells in Multiple Sclerosis.

Authors:  Saige L Pompura; David A Hafler; Margarita Dominguez-Villar
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

3.  Oleic acid restores suppressive defects in tissue-resident FOXP3 Tregs from patients with multiple sclerosis.

Authors:  Saige L Pompura; Allon Wagner; Alexandra Kitz; Jacob LaPerche; Nir Yosef; Margarita Dominguez-Villar; David A Hafler
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

4.  Current and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation.

Authors:  Undurti N Das
Journal:  J Inflamm Res       Date:  2010-12-02

5.  Chronic Arachidonic Acid Administration Decreases Docosahexaenoic Acid- and Eicosapentaenoic Acid-Derived Metabolites in Kidneys of Aged Rats.

Authors:  Masanori Katakura; Michio Hashimoto; Takayuki Inoue; Abdullah Al Mamun; Yoko Tanabe; Makoto Arita; Osamu Shido
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.